Overview

BIOAVAILABILITY OF GLI/METXR (4/850 mg)

Status:
Completed

Trial end date:
2011-03-01

Target enrollment:

Participant gender:

Summary

Objective: The purpose of this study is to evaluate the oral bioavailability of the combination Glimepiride/ extended release Metformin (GLI/METXR) (4/850mg) in healthy Mexican volunteers in fasting conditions. Methods: A prospective, longitudinal, open label, non randomized study, was performed, 24 volunteers were administrated with a single oral dose of GLI/METXR (4/850 mg).

Phase:

Phase 1

Details

Lead Sponsor:

Laboratorios Silanes S.A. de C.V.

Collaborator:

Instituto Mexicano del Seguro Social

Treatments:

Glimepiride
Metformin